Centene Corporation provides a portfolio of services to government-sponsored healthcare programs, focusing on under-insured and uninsured individuals. The company was founded in 1984 and is based in St. Louis, Missouri.
CNC Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for CNC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Centene Corp ranked in the 47th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 16.5%. In terms of the factors that were most noteworthy in this DCF analysis for CNC, they are:
Centene Corp's weighted average cost of capital (WACC) is 7%; for context, that number is higher than only 8.5% of tickers in our DCF set.
As a business, Centene Corp experienced a tax rate of about 24% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 87.69% of stocks generating free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CNC, try HAE, HRC, EBS, REGN, and HBIO.
Centene (CNC) has priced its public offering of $2.2B aggregate principal amount of 3.00% senior notes due 2030.Closing date is October 7. Net proceeds along with cash on hand will be used to redeem notes, including all premiums, accrued interest and costs and expenses related to the 2022 notes redemption...
Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced today that it has priced its previously announced underwritten public offering of $2,200,000,000 aggregate principal amount of 3.00% senior notes due 2030 (the "Notes"). The offering is expected to close on or about October 7, 2020, subject to customary closing conditions.
Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced today that it has commenced an underwritten public offering to sell $2,200,000,000 of senior notes due 2030 (the "Notes"), subject to market and other conditions.